Logo image of DLTH

DULUTH HOLDINGS INC - CL B (DLTH) Stock Fundamental Analysis

NASDAQ:DLTH - Nasdaq - US26443V1017 - Common Stock - Currency: USD

1.95  +0.07 (+3.72%)

Fundamental Rating

1

Taking everything into account, DLTH scores 1 out of 10 in our fundamental rating. DLTH was compared to 121 industry peers in the Specialty Retail industry. Both the profitability and financial health of DLTH have multiple concerns. DLTH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DLTH had negative earnings in the past year.
In the past year DLTH has reported a negative cash flow from operations.
In multiple years DLTH reported negative net income over the last 5 years.
In multiple years DLTH reported negative operating cash flow during the last 5 years.
DLTH Yearly Net Income VS EBIT VS OCF VS FCFDLTH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

With a Return On Assets value of -9.65%, DLTH is not doing good in the industry: 76.86% of the companies in the same industry are doing better.
DLTH has a worse Return On Equity (-23.91%) than 62.81% of its industry peers.
Industry RankSector Rank
ROA -9.65%
ROE -23.91%
ROIC N/A
ROA(3y)-3.75%
ROA(5y)-0.57%
ROE(3y)-9.12%
ROE(5y)-1.44%
ROIC(3y)N/A
ROIC(5y)N/A
DLTH Yearly ROA, ROE, ROICDLTH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1.3 Margins

With a decent Gross Margin value of 49.23%, DLTH is doing good in the industry, outperforming 76.86% of the companies in the same industry.
DLTH's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for DLTH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.04%
GM growth 5Y-1.57%
DLTH Yearly Profit, Operating, Gross MarginsDLTH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

2

2. Health

2.1 Basic Checks

DLTH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DLTH has more shares outstanding
The number of shares outstanding for DLTH has been increased compared to 5 years ago.
DLTH has about the same debt/assets ratio as last year.
DLTH Yearly Shares OutstandingDLTH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DLTH Yearly Total Debt VS Total AssetsDLTH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

DLTH has an Altman-Z score of 1.73. This is a bad value and indicates that DLTH is not financially healthy and even has some risk of bankruptcy.
DLTH has a worse Altman-Z score (1.73) than 61.98% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that DLTH is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.30, DLTH perfoms like the industry average, outperforming 57.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 1.73
ROIC/WACCN/A
WACC9.68%
DLTH Yearly LT Debt VS Equity VS FCFDLTH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

DLTH has a Current Ratio of 1.49. This is a normal value and indicates that DLTH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.49, DLTH is in line with its industry, outperforming 57.85% of the companies in the same industry.
A Quick Ratio of 0.20 indicates that DLTH may have some problems paying its short term obligations.
DLTH has a Quick ratio of 0.20. This is amonst the worse of the industry: DLTH underperforms 86.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 0.2
DLTH Yearly Current Assets VS Current LiabilitesDLTH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for DLTH have decreased strongly by -146.21% in the last year.
The Revenue has decreased by -3.11% in the past year.
DLTH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.36% yearly.
EPS 1Y (TTM)-146.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.95%
Revenue 1Y (TTM)-3.11%
Revenue growth 3Y-3.56%
Revenue growth 5Y0.36%
Sales Q2Q%-1.77%

3.2 Future

Based on estimates for the next years, DLTH will show a very negative growth in Earnings Per Share. The EPS will decrease by -29.28% on average per year.
DLTH is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -6.10% yearly.
EPS Next Y-84.29%
EPS Next 2Y-29.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-10.69%
Revenue Next 2Y-6.1%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DLTH Yearly Revenue VS EstimatesDLTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
DLTH Yearly EPS VS EstimatesDLTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DLTH. In the last year negative earnings were reported.
Also next year DLTH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DLTH Price Earnings VS Forward Price EarningsDLTH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DLTH is valued a bit more expensive than the industry average as 65.29% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 38.72
DLTH Per share dataDLTH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as DLTH's earnings are expected to decrease with -29.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-29.28%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DLTH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DULUTH HOLDINGS INC - CL B

NASDAQ:DLTH (5/12/2025, 8:13:49 PM)

1.95

+0.07 (+3.72%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-13 2025-03-13/bmo
Earnings (Next)05-28 2025-05-28/bmo
Inst Owners27.66%
Inst Owner Change0.13%
Ins Owners27.33%
Ins Owner Change10.03%
Market Cap70.18M
Analysts47.5
Price Target2.04 (4.62%)
Short Float %2.75%
Short Ratio6.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-81.84%
Min EPS beat(2)-138.06%
Max EPS beat(2)-25.61%
EPS beat(4)1
Avg EPS beat(4)-34.29%
Min EPS beat(4)-138.06%
Max EPS beat(4)86.93%
EPS beat(8)2
Avg EPS beat(8)-155.55%
EPS beat(12)4
Avg EPS beat(12)-107.15%
EPS beat(16)8
Avg EPS beat(16)-14.92%
Revenue beat(2)0
Avg Revenue beat(2)-7.02%
Min Revenue beat(2)-7.58%
Max Revenue beat(2)-6.46%
Revenue beat(4)1
Avg Revenue beat(4)-2.69%
Min Revenue beat(4)-7.58%
Max Revenue beat(4)6.71%
Revenue beat(8)2
Avg Revenue beat(8)-1.86%
Revenue beat(12)3
Avg Revenue beat(12)-2.08%
Revenue beat(16)5
Avg Revenue beat(16)-1.24%
PT rev (1m)-27.27%
PT rev (3m)-42.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-64.39%
EPS NY rev (1m)-20%
EPS NY rev (3m)-156.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.38
P/tB 0.39
EV/EBITDA 38.72
EPS(TTM)-0.71
EYN/A
EPS(NY)-1.32
Fwd EYN/A
FCF(TTM)-0.7
FCFYN/A
OCF(TTM)-0.47
OCFYN/A
SpS17.41
BVpS5.08
TBVpS5.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.65%
ROE -23.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.23%
FCFM N/A
ROA(3y)-3.75%
ROA(5y)-0.57%
ROE(3y)-9.12%
ROE(5y)-1.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.04%
GM growth 5Y-1.57%
F-Score2
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 17.33
Cap/Depr 25.8%
Cap/Sales 1.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.49
Quick Ratio 0.2
Altman-Z 1.73
F-Score2
WACC9.68%
ROIC/WACCN/A
Cap/Depr(3y)84.18%
Cap/Depr(5y)65.82%
Cap/Sales(3y)4.14%
Cap/Sales(5y)3.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-146.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.95%
EPS Next Y-84.29%
EPS Next 2Y-29.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.11%
Revenue growth 3Y-3.56%
Revenue growth 5Y0.36%
Sales Q2Q%-1.77%
Revenue Next Year-10.69%
Revenue Next 2Y-6.1%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-233.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year156.96%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-142.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-143.74%
OCF growth 3YN/A
OCF growth 5YN/A